The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO), has granted a favourable recommendation for marketing permission of Wockhardt's novel antibiotic, Zaynich ...

The study, published in The Lancet Infectious Diseases, found that, among patients hospitalized with a difficult-to-treat (DTR) gram-negative bacterial infections, initial treatment with one of six ...

Antibiotics revolutionized health care when they were introduced in the early twentieth century, making many severe and often ...

Wockhardt said that it has received a favourable recommendation from the Central Drugs Standard Control Organization's Subject Expert Committee for marketing approval of its novel antibiotic Zaynich ...

The Brazilian National Institute of Industrial Property has granted a Family 4 patent covering lead compounds RECCE 327 and ...

A recent study shows how quickly germs teem on unwashed bedding. Here are 5 expert-approved steps to effectively kill those germs today ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections ...

A similar story can surface in surgical settings, where dropped objects are surprisingly common. But a new randomized study ...

Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the "Company" or "Iterum" or "we"), a company focused on delivering next generation ...

Food and Drug Administration reported Thursday. The maker of the products, California-based Raw Farm, continues to deny the ...